CompletedPhase 2NCT02301039
SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas
Studying Bone sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Principal Investigator
- Hussein Tawbi, MD, PhDM.D. Anderson Cancer Center
- Intervention
- Pembrolizumab(drug)
- Enrollment
- 144 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2015 – 2020
Study locations (12)
- University of Southern California, Los Angeles, California, United States
- Medstar Health Research Institute, Washington D.C., District of Columbia, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- H. Lee Moffitt Cancer Center, Tampa, Florida, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Mayo Clinic Cancer Center, Rochester, Minnesota, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Duke University, Durham, North Carolina, United States
- Oregon Health and Science University, Portland, Oregon, United States
- Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Collaborators
Merck Sharp & Dohme LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02301039 on ClinicalTrials.govOther trials for Bone sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07479732Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic OsteosarcomaPeking University People's Hospital
- RECRUITINGPHASE1NCT07222735Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory SarcomasSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07359053MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced SarcomaShanghai 6th People's Hospital
- RECRUITINGPHASE2NCT06939855QL1706 in the Treatment of Advanced Bone and Soft Tissue SarcomaSun Yat-sen University
- RECRUITINGNCT07215611Financial Toxicity in Patients With Resected Soft Tissue and Bone SarcomasM.D. Anderson Cancer Center
- RECRUITINGNCT06958107LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma PatientsWake Forest University Health Sciences
- RECRUITINGPHASE1, PHASE2NCT07066982Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced SarcomasEssen Biotech
- RECRUITINGNANCT06796543Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone SarcomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins